Author

David Kann

WellSpan Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 2 Research Focus:GWAS / association mapping· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Alexandre BolzeiD· 2 shared Ashley Arana Waring· 2 shared Basil KhuderiD· 2 shared C. Anwar A. ChahaliD· 2 shared Christopher N. Chapman· 2 shared Douglas A. Olson· 2 shared Douglas A. StolleriD· 2 shared Elizabeth T. CirulliiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Alexandre BolzeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Matthew E. Levy, Kelly M. Schiabor Barrett, Megan N. Betts, David Kann, Alexandre Bolze, Basil Khuder, Natalie Telis, Lisa M. McEwen, Amy Curry Sturm, Chad R. Haldeman‐Englert, Jeremy Cauwels, Douglas A. Stoller, C. Anwar A. Chahal, Christopher N. Chapman, Ashley Arana Waring, , Catherine A. Hajek

Population genomic screening identified familial hypercholesterolemia patients, leading to improved lipid-lowering therapies and LDL-C reductions.

Circulation Genomic and Precision Medicine · Nov 5, 2025Peer-reviewedGenetic & Genomic Medicine

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Natalie Telis, Hang Dai, Ashley Arana Waring, David Kann, Dana Wyman, Simon J. White, Basil Khuder, Francisco Tanudjaja, Alexandre Bolze, Matthew E. Levy, Cassie Hajek, Lisa M. McEwen, Douglas A. Stoller, Christopher N. Chapman, C. Anwar A. Chahal, , Kelly M. Schiabor Barrett

This paper develops a method to predict Lp(a) levels from genomic data, combining SNV risk scores and KIV-2 repeat counts, and shows it improves risk prediction for cardiovascular disease in diverse populations.

medRxiv · Nov 1, 2024 · PreprintGenetic & Genomic Medicine